Brupharma SRL
0.1 FTEThe score of Brupharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -32 % Total assets -12 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 18 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Brupharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −743 € | ||||
| Equity | 174,489 € | ||||
| Cash | 183,705 € | ||||
| EBITDA | 67,386 € | ||||
| Total assets | 360,003 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Brupharma's financial analysis
- Solvency48.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Brupharma
Brupharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0407.579.845
- VAT number
- BE0407579845
- Peppol
- Registered · 0208:0407579845 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Nov 1970
- Registered office
- 8000 Bruges
- Size
- Micro · 0.1 FTE
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Brupharma (SRL) has been based in Bruges since 1970, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 743 € and equity of 174,489 €; its revenue is not published. With 0.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 48.5%, above the median of its sector (44.2%).
Companies similar to Brupharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Dampoort Retail sale of pharmaceutical products Bruges · balance sheet 357,644 €
- Pharma 5 Retail sale of pharmaceutical products Etterbeek · balance sheet 359,207 €
- Société Pharmaceutique belge Retail sale of pharmaceutical products Saint-Gilles · balance sheet 358,883 €
- Charlotte DE Chaffoy Retail sale of pharmaceutical products Brussels · balance sheet 361,413 €
- Groot Zand Retail sale of pharmaceutical products Dendermonde · balance sheet 358,515 €
- Pharmacie Lonneux Retail sale of pharmaceutical products Liège · balance sheet 358,360 €
- Pharmabak Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 357,515 €
- Cobea Pharma Retail sale of pharmaceutical products Villers-la-Ville · balance sheet 362,823 €
Frequently asked questions about Brupharma
What is the revenue of Brupharma?
Brupharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Brupharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0407579845 for Brupharma, if the company is VAT-registered. Its company number (CBE) is 0407.579.845.
Where is the registered office of Brupharma?
According to the CBE register, the registered office of Brupharma is in 8000 Bruges.
What is the equity of Brupharma?
At the close of the 2025 financial year, the equity of Brupharma amounts to 174,489 €, a solvency of 48.5% of total assets.
How many people work at Brupharma?
0.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Brupharma?
The register lists 1 active mandates at Brupharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Brupharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →